(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-234 Puritas ≥99.0% ee ≥99.0% Linagliptin Alogliptin Trelagliptin Intermedium
Commercial Supple Alogliptin Benzoate (CAS: 850649-62-6) Intermedia:
6-Chloro-3-methyluracil CAS: 4318-56-3
2-Cyanobenzyl Bromide CAS: 22115-41-9
(R)-(-)-3-Aminopiperidine dihydrochloride CAS: 334618-23-4
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS: 865758-96-9
Supple Commercial Trelagliptin Succinate (CAS: 1029877-94-8) Intermedia:
6-Chloro-3-Methyluracil CAS: 4318-56-3
(R)-(-)-3-Aminopiperidine dihydrochloride CAS: 334618-23-4
2-Cyano-5-Flurobenzyl Bromide CAS: 421552-12-7
Nomen chemicum | (R)-(-)-3-Aminopiperidine dihydrochloride |
Synonyma | (R)-(-)-3-Piperidinamine Dihydrochloride |
CAS Number | 334618-23-4 |
CATTUS Number | RF-PI140 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C5H12N2·2HCl |
M. Pondus | 173.08 |
Liquescens punctum | 190.0~ 195.0℃ |
Solubilitas | Solutum in aqua |
Shipping Condition | Uit sub Ambient Temperature |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Solidus albus |
IR | Conformed |
Puritas chemica | ≥99.0% (HPLC) |
Omnis immunditia | ≤0.20% |
Optical Puritas | e ≥99.0% |
Humor (KF) | ≤0.50% |
Residere in Ignition | ≤0.10% |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Linagliptin, Alogliptin, Trelagliptin, Saxagliptin |
sarcina: Utrem, aluminium foil sacculum, 25kg/tympanum cardboard, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Lucem protege, humorem.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum (R)-(-)-3-Aminopiperidine dihydrochloridis (CAS: 334618-23-4) cum qualitate magna, in synthesi organica late adhibita, synthesis intermediorum pharmaceutical. et activum medicamentum pharmaceuticum (API) synthesis, suach ut Alogliptin Benzoate (CAS: 850649-62-6), Trelagliptin Succinatum (CAS: 1029877-94-8), Linagliptin (CAS 668270-12-0).
Alogliptin Benzoate (CAS: 850649-62-6) est medicamentum diabete typum 2 et est genus protease dipeptidyli peptidasi serinae IV (DPP-4) inhibitoris.Alogliptin, solum vel in coniunctione cum aliis medicamentis sanguinem saccharo demissis, fere bene tolerari solet in aegrotis 2 diabetis speciebus.
Trelagliptin Succinatus (CAS: 1029877-94-8) (SYR-472) selectivum, dipeptidylum peptidase-4 (DPP-4) inhibitor adhibitus ad tractationem speciei 2 diabete melliti.Antidiabeticum agens.Trelagliptin Succinatus usus in Iaponia mense Martio MMXV probatus est.